CA2332993A1 - Phagocytic assay method - Google Patents

Phagocytic assay method Download PDF

Info

Publication number
CA2332993A1
CA2332993A1 CA002332993A CA2332993A CA2332993A1 CA 2332993 A1 CA2332993 A1 CA 2332993A1 CA 002332993 A CA002332993 A CA 002332993A CA 2332993 A CA2332993 A CA 2332993A CA 2332993 A1 CA2332993 A1 CA 2332993A1
Authority
CA
Canada
Prior art keywords
cell
apoptotic
cells
sequence
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002332993A
Other languages
English (en)
French (fr)
Inventor
Elke Smits
Wim Maria Rene Van Criekinge
Thierry Andre Oliver Eddy Bogaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9812660.0A external-priority patent/GB9812660D0/en
Priority claimed from GBGB9820816.8A external-priority patent/GB9820816D0/en
Application filed by Individual filed Critical Individual
Publication of CA2332993A1 publication Critical patent/CA2332993A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002332993A 1998-06-11 1999-06-10 Phagocytic assay method Abandoned CA2332993A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9812660.0 1998-06-11
GBGB9812660.0A GB9812660D0 (en) 1998-06-11 1998-06-11 Engulfment gene and uses thereof
GBGB9820816.8A GB9820816D0 (en) 1998-09-24 1998-09-24 Engulfment gene and uses thereof
GB9820816.8 1998-09-24
PCT/EP1999/004043 WO1999064586A2 (en) 1998-06-11 1999-06-10 Phagocytic assay method

Publications (1)

Publication Number Publication Date
CA2332993A1 true CA2332993A1 (en) 1999-12-16

Family

ID=26313846

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002332993A Abandoned CA2332993A1 (en) 1998-06-11 1999-06-10 Phagocytic assay method

Country Status (11)

Country Link
EP (1) EP1084242A2 (pt)
JP (1) JP2002517238A (pt)
KR (1) KR20010071453A (pt)
CN (1) CN1305525A (pt)
AU (1) AU4608499A (pt)
BR (1) BR9911097A (pt)
CA (1) CA2332993A1 (pt)
HU (1) HUP0102349A2 (pt)
IL (1) IL140016A0 (pt)
PL (1) PL345951A1 (pt)
WO (1) WO1999064586A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020004041A1 (en) * 1999-02-19 2002-01-10 Albert Matthew L. Methods for abrogating a cellular immune response
US6489535B1 (en) 1999-03-18 2002-12-03 The Board Of Trustees Of The Leland Stanford Junior University Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype
US6316690B1 (en) 1999-08-04 2001-11-13 Tosk, Inc. Non-mammalian transgenic animal model for cellular proliferative diseases
US6365129B1 (en) 1999-08-04 2002-04-02 Tosk, Inc. Invivo high throughput toxicology screening method
US7615676B2 (en) 2001-11-30 2009-11-10 U.S. Department Of Veterans Affairs Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production
US7491810B2 (en) * 2001-11-30 2009-02-17 U.S. Department Of Veterans Affairs Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production
WO2018212612A1 (ko) * 2017-05-17 2018-11-22 울산과학기술원 자성 입자를 이용한 면역세포의 평가 방법 및 장치
KR102213080B1 (ko) * 2017-05-17 2021-02-08 울산과학기술원 자성 입자를 이용한 면역세포의 평가방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232061B1 (en) * 1992-04-01 2001-05-15 Cambridge Neuroscience, Inc. Homology cloning

Also Published As

Publication number Publication date
HUP0102349A2 (hu) 2001-10-28
JP2002517238A (ja) 2002-06-18
AU4608499A (en) 1999-12-30
EP1084242A2 (en) 2001-03-21
WO1999064586A3 (en) 2000-04-27
PL345951A1 (en) 2002-01-14
CN1305525A (zh) 2001-07-25
KR20010071453A (ko) 2001-07-28
IL140016A0 (en) 2002-02-10
WO1999064586A2 (en) 1999-12-16
BR9911097A (pt) 2001-02-13

Similar Documents

Publication Publication Date Title
Heck et al. The kinesin-like protein KLP61F is essential for mitosis in Drosophila.
Sen et al. Spatially restricted expression of pipe in the Drosophila egg chamber defines embryonic dorsal–ventral polarity
Thomas et al. The Drosophila gene Serrate encodes an EGF-like transmembrane protein with a complex expression pattern in embryos and wing discs
Yucel et al. CENP-meta, an essential kinetochore kinesin required for the maintenance of metaphase chromosome alignment in Drosophila
Doherty et al. The Drosophila neurogenic gene big brain, which encodes a membrane-associated protein, acts cell autonomously and can act synergistically with Notch and Delta
Granato et al. Genesis of an organ: molecular analysis of the pha-1 gene
Cuppen et al. Identification and molecular characterization of BP75, a novel bromodomain-containing protein
US7803920B2 (en) ECAT16 gene expressed specifically in ES cells and utilization of the same
CA2332993A1 (en) Phagocytic assay method
CA2373628A1 (en) Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
Stepanik et al. FGF pyramus has a transmembrane domain and cell-autonomous function in Polarity
US6579701B1 (en) Drosophila homologues of genes and proteins implicated in cancer and methods of use
ZA200006646B (en) Phagocytic assay method.
US6781028B1 (en) Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
US6599717B1 (en) Invertebrate vascular endothelial growth factor receptor
Goszczynski Investigation into the Functional Significance of de2f1a-specific Interaction with the RB-family Protein in Drosophila Melanogaster Development
Fu Identification and characterization of E2a-Pbx1 target genes in NIH3T3 fibroblasts and pre-B ALL cells
Laub et al. Overexpression of a novel zinc-finger protein induces apoptosis in NIH3T3 fibroblasts
US20050089858A1 (en) Salvador tumor suppressor gene
JP5099534B2 (ja) Ｋａｎｋ３遺伝子の癌治療及び癌検出並びに創薬への利用
VanHouten MIPP, an actin-binding protein often ectopically expressed in BALB/c mouse mammary carcinomas, is associated with the endoplasmic reticulum, and inhibits extracellular matrix-induced mammary structure formation in vitro
Balicky Regulation of chromosome segregation by ORD and dRING during Drosophila meiosis
Civill Characterisation of a bagpipe homologue in Xenopus laevis
Jones Molecular, cellular, and biochemical analyses of gld-1, a gene involved in multiple aspects of germline development in Caenorhabditis elegans
Dong Studies of Drosophila sex-lethal protein interactions and cloning of a novel interactor, Sin

Legal Events

Date Code Title Description
FZDE Discontinued